A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association
Information & Authors
Information
Published In
Copyright
Copyright © 1975 by American Heart Association.
History
Published online: 1 April 1975
Published in print: April 1975
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Evaluating Total Atherosclerosis Burden of Baroreceptor-Resident Arteries after Ischemic Cerebrovascular Disease for Identifying Patients with Heavy Coronary Atherosclerosis Burden, Journal of Atherosclerosis and Thrombosis, 31, 4, (429-443), (2024).https://doi.org/10.5551/jat.64457
- Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD Study, Journal of Atherosclerosis and Thrombosis, 31, 1, (61-80), (2024).https://doi.org/10.5551/jat.64304
- Correlation of neutrophil to lymphocyte ratio to severity of coronary artery disease and in-hospital clinical outcomes in patients with acute coronary syndrome: A prospective observational study, Journal of Acute Disease, 13, 1, (14-19), (2024).https://doi.org/10.4103/jad.jad_139_23
- Right and Left Coronary and Conus Arteries Originating from Three Separate Ostia in the Right Valsalva Sinus in a Japanese Cadaver: A Case Study with Literature Review, Medicina, 60, 5, (730), (2024).https://doi.org/10.3390/medicina60050730
- Type 2 diabetes mellitus aggravates coronary atherosclerosis in hypertensive individuals based on coronary CT angiography: a retrospective propensity score-based study, Frontiers in Cardiovascular Medicine, 11, (2024).https://doi.org/10.3389/fcvm.2024.1372519
- Chinese herbal compound preparation Qing-Xin-Jie-Yu granules for intermediate coronary lesions in patients with stable coronary artery disease: Study protocol for a multicenter, randomized, double-blind, placebo-controlled trial, PLOS ONE, 19, 7, (e0307074), (2024).https://doi.org/10.1371/journal.pone.0307074
- Extracellular Volume Fraction by Computed Tomography Predicts Prognosis After Transcatheter Aortic Valve Replacement, Circulation Journal, 88, 4, (492-500), (2024).https://doi.org/10.1253/circj.CJ-23-0288
- Residual Coronary Risk Factors Associated With Long-Term Clinical Outcomes in Patients With Coronary Artery Disease Treated With High- vs. Low-Dose Statin Therapy ― REAL-CAD Substudy ―, Circulation Journal, 88, 6, (995-1003), (2024).https://doi.org/10.1253/circj.CJ-23-0134
- Transgender Women With Suppressed Testosterone Display Lower Burden of Coronary Disease Than Matched Cisgender Men, Journal of the Endocrine Society, 8, 8, (2024).https://doi.org/10.1210/jendso/bvae120
- Aggravating effect of abnormal low-density protein cholesterol level on coronary atherosclerotic plaque in type 2 diabetes mellitus patients assessed by coronary computed tomography angiography, Cardiovascular Diabetology, 23, 1, (2024).https://doi.org/10.1186/s12933-024-02304-0
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.